单细胞测序技术及其在阿尔茨海默病中的应用
Yuru Han1,2,3, Congying Huang1,2,3, Yuhui Pan4
1Shanghai Key Laboratory of Molecular Imaging, Zhoupu Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, China.
Journal of Alzheimer's disease : JAD
|January 13, 2024
概括
单细胞测序通过检查单个脑细胞,为研究阿尔茨海默病 (AD) 提供了新的途径. 这项技术有助于克服诊断和理解AD的挑战.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 生物技术是生物技术.
背景情况:
- 阿尔茨海默病 (AD) 的特点是脑细胞退化,由于进展缓慢,往往被诊断为晚期.
- 目前对AD的诊断和治疗策略面临着重大挑战.
- 传统的批量测序方法未能捕捉到细胞异质性,这对于理解AD等复杂疾病至关重要.
研究的目的:
- 提供新兴单细胞测序技术的概述.
- 突出这些先进技术在阿尔茨海默病研究中的应用.
- 强调单细胞分析在研究复杂神经系统疾病中的优势.
主要方法:
- 审查当前的单细胞测序技术,包括转录组学,表观组学,基因组学和蛋白质组学.
- 分析这些技术的应用,以了解阿尔茨海默病的发病因子.
- 讨论单细胞分辨率对研究中枢神经系统复杂性的好处.
主要成果:
- 单细胞测序技术为研究大脑细胞异质性提供了前所未有的分辨率.
- 这些方法对复杂疾病的传统批量测序具有显著的优势.
- 单细胞技术的快速进步正在扩大它们在AD研究中的实用性.
结论:
- 单细胞测序是解开阿尔茨海默病复杂性的强大工具.
- 了解细胞异质性是改善AD诊断和治疗的关键.
- 审查的单细胞技术代表了神经疾病研究的重大飞跃.
相关概念视频
RNA-seq
10.0K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
10.0K
Next-generation Sequencing
88.9K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.9K
Alzheimer's Disease: Overview
490
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
490


